Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

LÆGEHUSET DAGMAR ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   3.1% 2.5% 3.9% 6.9% 4.2% 3.9% 21.1% 21.1%   Credit score (0-100)   58 62 48 34 47 50 5 5   Credit rating   BBB BBB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   9,099 9,374 8,568 9,129 10,127 10,459 0.0 0.0   EBITDA   1,223 911 966 771 2,241 1,588 0.0 0.0   EBIT   605 227 220 12.6 1,566 1,223 0.0 0.0   Pre-tax profit (PTP)   565.6 184.7 183.1 -28.2 1,517.0 1,158.4 0.0 0.0   Net earnings   440.7 139.7 141.6 -24.0 1,180.5 895.7 0.0 0.0   Pre-tax profit without non-rec. items   566 185 183 -28.2 1,517 1,158 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   85.0 826 825 632 440 247 0.0 0.0   Shareholders equity total   521 980 222 56.0 1,236 976 0.2 0.2   Interest-bearing liabilities   923 1,500 1,357 863 670 500 0.0 0.0   Balance sheet total (assets)   3,816 4,387 2,811 1,972 3,080 2,413 0.2 0.2   Net Debt   480 682 1,352 861 -397 -297 -0.2 -0.2     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   9,099 9,374 8,568 9,129 10,127 10,459 0.0 0.0   Gross profit growth   10.1% 3.0% -8.6% 6.6% 10.9% 3.3% -100.0% 0.0%   Employees   13 14 12 13 13 13 0 0   Employee growth %   30.0% 7.7% -14.3% 8.3% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,816 4,387 2,811 1,972 3,080 2,413 0 0   Balance sheet change%   -8.6% 15.0% -35.9% -29.8% 56.2% -21.6% -100.0% 0.0%   Added value   1,222.7 910.9 965.8 770.9 2,324.2 1,587.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -1,181 -508 -1,313 -1,517 -1,351 -729 -247 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   6.6% 2.4% 2.6% 0.1% 15.5% 11.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   15.1% 5.5% 6.1% 0.5% 62.0% 44.5% 0.0% 0.0%   ROI %   25.2% 9.6% 9.3% 0.9% 105.9% 72.2% 0.0% 0.0%   ROE %   45.9% 18.6% 23.6% -17.3% 182.7% 81.0% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   13.6% 22.3% 7.9% 2.8% 40.1% 40.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   39.3% 74.9% 140.0% 111.7% -17.7% -18.7% 0.0% 0.0%   Gearing %   177.3% 153.1% 612.3% 1,543.0% 54.2% 51.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.7% 3.5% 2.5% 3.7% 6.4% 11.1% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.5 0.9 0.5 0.6 1.5 1.5 0.0 0.0   Current Ratio   0.5 0.9 0.5 0.6 1.5 1.5 0.0 0.0   Cash and cash equivalent   442.6 818.0 4.9 2.4 1,067.4 796.6 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,176.1 -272.4 -721.3 -436.6 641.0 561.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   94 65 80 59 179 122 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   94 65 80 59 172 122 0 0   EBIT / employee   47 16 18 1 120 94 0 0   Net earnings / employee   34 10 12 -2 91 69 0 0